Opus Genetics (IRD) EV to EBITDA (2022 - 2023)
Opus Genetics' (IRD) EV to EBITDA came in at 1.15 for Q3 2023, down 59.2% from the prior quarter.
Powered by 
Analysis
Opus Genetics (IRD) EV to EBITDA (2022 - 2023) Analysis & Trends
For the trailing twelve months through Sep 30, 2023, EV to EBITDA at Opus Genetics was -3.04; for FY2022, it was 1.70.
- According to Business Quant data, EV to EBITDA for the three prior quarters was 2.81 (Q2 2023), 2.12 (Q1 2023) and 1.70 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.68 Bn | 1,105.26 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.43 Bn | 535.95 Bn | 17.26 Bn |
| 3 | AbbVie | 501.53 Bn | 474.64 Bn | 12.70 Bn |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.54 Bn | 261.53 Bn | 11.24 Bn |
| 6 | Astrazeneca | 260.75 Bn | 234.43 Bn | 12.86 Bn |
| 7 | Amgen | 236.53 Bn | 191.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.10 Bn | 165.30 Bn | 6.22 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn |
| 10 | Opus Genetics | 394.82 Mn | 170.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 1.15 |
| Jun 30, 2023 | 2.81 |
| Mar 31, 2023 | 2.12 |
| Dec 31, 2022 | 1.70 |
API Access
Opus Genetics EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=IRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "IRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=IRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();